Government-Owned Inventions; Availability for Licensing, 20856 [E7-7927]

Download as PDF 20856 Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices and Child Health Coordinator, Maternal and Child Health Program, Indian Health Service, 801 Thompson Avenue, Suite 300, Rm 313, Rockville, Maryland 20852, voice: 301–443–5070, fax: 301– 594–6213 or judith.thierry@ihs.gov. For general information regarding this announcement: Ms. Orie Platero, IHS Headquarters, Office of Clinical and Preventive Services, 801 Thompson Avenue, Room 326, Rockville, MD 20852, (301) 443–2522 or orie.platero@ihs.gov. 3. For specific grant-related and business management information: Martha Redhouse, Grants Management Specialist, 801 Thompson Avenue, TMP 360, Rockville, MD 20852, 301–443– 5204 or Martha.redhouse@ihs.gov. VIII. Other Information The IHS is focusing efforts on three health initiatives that linked together, have the potential to achieve positive improvements in the health of American Indian and Alaska Native (AI/AN) people. These three initiatives are Health Promotion/Disease Prevention, Management of Chronic Disease, and Behavioral Health. Further information is available at the Health Initiatives Web site: https://www.ihs.gov/nonMedical/ Programs/DirInitiatives/index.cfm. This agreement supports the Department of Health and Human Services’ objective in FY 2006 to transform the health care system as well as the FY 2007 objective to emphasize prevention and healthy living as well as to accelerate personalized health care. Dated: April 19, 2007. Robert G. McSwain, Deputy Director, Indian Health Service. [FR Doc. 07–2051 Filed 4–25–07; 8:45 am] BILLING CODE 4165–16–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. rwilkins on PROD1PC63 with NOTICES AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage VerDate Aug<31>2005 18:59 Apr 25, 2007 Jkt 211001 for companies and may also be available for licensing. DEPARTMENT OF HEALTH AND HUMAN SERVICES Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. National Institutes of Health ADDRESSES: Apparatus for Brachytherapy Description of Technology: Available for licensing and commercial development is a device for delivering targeted radiation brachytherapy to a portion of tissue in the cavity of a patient. The device includes an applicator with a balloon where in a deflated state is inserted into the body cavity and in an inflated state enlarges to fill the body cavity. The balloon moves from the deflated state into the inflated state upon introduction of pressurized fluid to the interior of the balloon. The apparatus also includes a catheter extending over at least a portion of the balloon for delivering treatment to the adjacent cavity (e.g., radiation or heat). A tracking device (e.g., a camera) is included in the apparatus for helping track the positioning of the balloon within the body cavity prior to inflation. The apparatus can be alternatively configured with a second balloon containing a therapeutic agent which is inflated after positioning and expansion with a first balloon first. Applications: Brachytherapy; Radiation dosing; Cancer therapy. Development Status: Early-stage; Preclinical data available; Prototype. Inventor: Anurag K. Singh (NCI). Patent Status: U.S. Provisional Application No. 60/811,762 filed 08 Jun 2006 (HHS Reference No. E–314–2005/ 0–US–01). Licensing Status: Available for licensing non-exclusively or exclusively to qualified applicants that satisfy the criteria set forth in 37 CFR 404.7. Licensing Contact: Michael A. Shmilovich, Esq.; 301/435–5019; shmilovm@mail.nih.gov. Dated: April 18, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7–7927 Filed 4–25–07; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Biotinylated Alkylating Acridine for Pull-downs of Viral Pre-integration Complexes (PIC) or Other Cytosol Localized DNAs Description of Technology: The invention describes a DNA-binding molecule that allows recovery of viral DNA and associated proteins. An acridine orange based molecule was modified and the resulting alkylating acridine molecule intercalates with viral pre-integration complexes (PIC) or other DNAs localized in cytosol. Because the molecule is also biotinylated, streptavidin beads can be used to purify the molecule and the bound DNA and associated protein can subsequently be eluted and analyzed. The invention provides a useful tool to facilitate the studies for viral PIC and other cytosol DNAs. Applications: Research Tool. Development Status: In vitro data available. Inventors: Gunnar Thor Gunnarsson and Rafal Wierzchoslawski (NCI). Patent Status: HHS Reference No. E– 131–2007/0—Research Tool. Licensing Status: Available for nonexclusive licensing as biological material and research tool. Licensing Contact: Sally Hu, Ph.D.; 301/435–5606; HuS@mail.nih.gov. E:\FR\FM\26APN1.SGM 26APN1

Agencies

[Federal Register Volume 72, Number 80 (Thursday, April 26, 2007)]
[Notices]
[Page 20856]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7927]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federally-funded research and development. Foreign patent 
applications are filed on selected inventions to extend market coverage 
for companies and may also be available for licensing.

ADDRESSES: Licensing information and copies of the U.S. patent 
applications listed below may be obtained by writing to the indicated 
licensing contact at the Office of Technology Transfer, National 
Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, 
Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A 
signed Confidential Disclosure Agreement will be required to receive 
copies of the patent applications.

Apparatus for Brachytherapy

    Description of Technology: Available for licensing and commercial 
development is a device for delivering targeted radiation brachytherapy 
to a portion of tissue in the cavity of a patient. The device includes 
an applicator with a balloon where in a deflated state is inserted into 
the body cavity and in an inflated state enlarges to fill the body 
cavity. The balloon moves from the deflated state into the inflated 
state upon introduction of pressurized fluid to the interior of the 
balloon. The apparatus also includes a catheter extending over at least 
a portion of the balloon for delivering treatment to the adjacent 
cavity (e.g., radiation or heat). A tracking device (e.g., a camera) is 
included in the apparatus for helping track the positioning of the 
balloon within the body cavity prior to inflation. The apparatus can be 
alternatively configured with a second balloon containing a therapeutic 
agent which is inflated after positioning and expansion with a first 
balloon first.
    Applications: Brachytherapy; Radiation dosing; Cancer therapy.
    Development Status: Early-stage; Pre-clinical data available; 
Prototype.
    Inventor: Anurag K. Singh (NCI).
    Patent Status: U.S. Provisional Application No. 60/811,762 filed 08 
Jun 2006 (HHS Reference No. E-314-2005/0-US-01).
    Licensing Status: Available for licensing non-exclusively or 
exclusively to qualified applicants that satisfy the criteria set forth 
in 37 CFR 404.7.
    Licensing Contact: Michael A. Shmilovich, Esq.; 301/435-5019; 
shmilovm@mail.nih.gov.

    Dated: April 18, 2007.
Steven M. Ferguson,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer, National Institutes of Health.
[FR Doc. E7-7927 Filed 4-25-07; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.